Evidence map›Paper›PMID 41610005›Full record

ReviewMolecular diversity2026

Multicomponent reactions with Meldrum's acid and isocyanides as a valuable synthetic approach: An update.

Hadi Hassani Ardeshiri, Golnoosh Ghafari Tirabadi, Ahmad Shaabani

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hadi Hassani ArdeshiriDepartment of Organic Chemistry, Shahid Beheshti University, Daneshjou Boulevard, G.C., P.O. Box 1983963113, Tehran, Iran.
Golnoosh Ghafari TirabadiDepartment of Organic Chemistry, Shahid Beheshti University, Daneshjou Boulevard, G.C., P.O. Box 1983963113, Tehran, Iran.
Ahmad ShaabaniDepartment of Organic Chemistry, Shahid Beheshti University, Daneshjou Boulevard, G.C., P.O. Box 1983963113, Tehran, Iran. a-shaabani@sbu.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multicomponent reactions (MCRs) are one-pot processes in which at least three reactants are combined to assemble a novel target product by intrinsic molecular diversity, optimal atom economy, and high efficiency. The development and design of new MCRs that yield valuable chemical products represent a major focus in organic chemistry. Meldrum's acid is a distinctive β-keto ester that is crucial in organic synthesis, especially in MCRs. The C5 position of this molecule demonstrates significant reactivity towards electrophilic substitution, whereas the carbonyl centers at C4 and C6 are notably vulnerable to nucleophilic attack. Its dual characteristics as both a nucleophile and electrophile, along with its tendency for enolization and decarboxylation, render it an essential synthon for the effective assembly of various heterocyclic scaffolds and acyclic organic compounds. In parallel, isocyanides have attracted significant attention as a versatile building block in MCRs because of their unique ambident reactivity. The combination of Meldrum's acid with isocyanide has opened a powerful avenue in diversity-oriented synthesis, leading to the discovery of unexpected products such as succinimide, carboxamide, imino-furopyranones, cyclopenta[b] pyridines, benzodiazepines, benzooxazepines, amidodiesters, functionalized triamides, and enamides. In continuation of our earlier review on Meldrum's acid and isocyanide-based MCRs, this minireview covers an in-depth discussion of this field, especially focusing on the most recent results from 2015 to 2025.

Indexed as

Chemistry Techniques, SyntheticCyanidesDioxanesCyanidesDioxanesMeldrum's acidDiversity-oriented synthesisHeterocyclic scaffoldsIsocyanideMeldrum’s acidMulticomponent reactions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.